Prevalence and risk factors for type 2 diabetes mellitus with Prader–Willi syndrome: a single center experience

Table 4 Correlation analysis for microvascular complications and other variables in the diabetic group of PWS patients

Variables	Correlation coefficient
Variables	r	p-value^*
Age (years)	0.393	0.047
Age at diagnosis with PWS (years)	0.226	0.267
Age at diagnosis with T2DM (years)	0.104	0.613
HbA1C (%)	0.232	0.254
BMI, kg/m2 (SD)	0.133	0.517
HOMA-IR	0.434	0.027
Age at GHT start (years)	0.189	0.439
Previous GHT duration (years)	0.376	0.058
DM treatment duration (years)	0.370	0.063
From PWS diagnosis to DM diagnosis (years)	−0.156	0.446

Abbreviations: r Spearman correlation coefficient, T2DM type 2 Diabetes Mellitus, PWS Prader-Willi syndrome, HbA1C hemoglobin A1C, GHT growth hormone treatment, HOMA-IR homeostasis model assessment, BMI body mass index
^*Significant association was classified as p < 0.05

ISSN: 1750-1172